Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer.
Imai H, Saijo K, Komine K, Kawamura Y, Hiraide S, Umegaki S, Okada Y, Ohuchi K, Sato Y, Takahashi M, Takahashi S, Shirota H, Takahashi M, Ishioka C.
Imai H, et al. Among authors: okada y.
Cancer Manag Res. 2018 Sep 17;10:3629-3636. doi: 10.2147/CMAR.S170948. eCollection 2018.
Cancer Manag Res. 2018.
PMID: 30271211
Free PMC article.